Tiziana Life Sciences Announces Promising Immunologic Findings of Nasal Foralumab in Alzheimer's Disease

Tiziana Life Sciences announced compelling immunologic findings from a moderate Alzheimer's Disease patient treated with intranasal foralumab. Transc...
Home/KnloSights/Clinical Trial Updates/Tiziana Life Sciences Announces Promising Immunologic Findings of Nasal Foralumab in Alzheimer's Disease